Patient-reported Quality of Life in Patients with Primary Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy with and Without Concurrent Radiation Therapy to the Prostate in a Prospective Randomised Clinical Trial; Data from the HORRAD Trial-Reference-Cited by-同舟云学术

Patient-reported Quality of Life in Patients with Primary Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy with and Without Concurrent Radiation Therapy to the Prostate in a Prospective Randomised Clinical Trial; Data from the HORRAD Trial

Published:2021-02 Issue:2 Volume:79 Page:188-197
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Boevé Liselotte^ORCID,Hulshof Maarten C.C.M.,Verhagen Paul C.M.S.,Twisk Jos W.R.,Witjes Wim P.J.,de Vries Peter,van Moorselaar R. Jeroen A.,van Andel George,Vis André N.

Funder

AstraZeneca

Ipsen

Publisher

Elsevier BV

Subject

Urology

Reference12 articles.

1. Effect on survival of androgen deprivation therapy alone compared to androgen deprivation therapy combined with concurrent radiation therapy to the prostate in patients with primary bone metastatic prostate cancer in a prospective randomised clinical trial;Boevé;Eur Urol,2019

2. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial;Parker;Lancet,2018

3. Prostate radiotherapy for metastatic hormone-sensitive prostate cancer: a STOPCAP systematic review and meta-analysis;Burdett;Eur Urol,2019

4. Mottet N., van den Bergh R.C.N., Briers E., et al. EAU guidelines.

5. Quality of life and satisfaction with outcome among prostate cancer survivors;Sanda;N Engl J Med,2008

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgen deprivation alone versus combined with pelvic radiation for adverse events and quality of life in clinically node-positive prostate cancer;Scientific Reports;2024-04-08

2. Does Radical Local Treatment in Oligometastatic Prostate Cancer Improve Overall Survival: A Systematic Review and Meta-analysis;Urology;2023-12

3. Microbiome and metabolome dynamics during radiotherapy for prostate cancer;Radiotherapy and Oncology;2023-12

5. Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US;Quality of Life Research;2023-07-06